Colin Kelley is an Operating Partner for Merida Capital Holdings where he oversees operations in Michigan, Missouri, Virginia, Pennsylvania, Maryland, and West Virginia; he also serves as a board member for Brytemap. Additionally, Kelley is a board member of LeafLine Labs, one of two licensed producers and distributors of medical cannabis in Minnesota. He leads LeafLine’s CBD brands, Happy Place™ and SOAR™.
Prior to Merida, Kelley served as the Chief Financial Officer and Chief Operating Officer of LeafLine Labs. Additionally, he has held management roles at Dun & Bradstreet, Investors Bank & Trust, Wind River Capital Management, and Fresenius Medical Care. He has consulted to the SAP Business Incubator and the Civilian Research & Development Fund. Kelley earned his BSBA in Management and Finance from Bryant University in Rhode Island.